Exploring the Mechanism of <i>Astragalus propinquus</i> Schischkin and <i>Panax Notoginseng</i> (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis

<div>Analysis of network pharmacology and differential analysis. (a) Regulatory network of TCM compound prescription (note: blue represents the potential active component of <i>Panax notoginseng</i>; Purple represents Cambrian; red represents <i>Astragalus membranaceus</i>; green stands for <i>Achyranthes bidentata</i>; yellow represents the core gene.). (b) Differential gene analysis of disease-targets by microarrays.</div>

Evidence-Based Complementary and Alternative Medicine

fig4

Figure 4

Figure 4: Exploring the Mechanism of <i>Astragalus propinquus</i> Schischkin and <i>Panax Notoginseng</i> (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis 

Figure 4 | Exploring the Mechanism of Astragalus propinquus Schischkin and Panax Notoginseng (A&P) Compounds in the Treatment of Renal Fibrosis and Chronic Kidney Disease Based on Integrated Network Analysis 